SCHEMBL3301785

SCHEMBL3301785

CCCCCC(C)(C)Oc1cc(OC(C)(C)CCCCC)cc([SiH](O[SiH](c2cc(OC(C)(C)CCCCC)cc(OC(C)(C)CCCCC)c2)c2cc(OC(C)(C)CCCCC)cc(OC(C)(C)CCCCC)c2)c2cc(OC(C)(C)CCCCC)cc(OC(C)(C)CCCCC)c2)c1

nearest known ligand 0.31

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 7/20 0.31
▸ CNR1 P21554 6/20 0.30
▸ KDM4E B2RXH2 1/20 0.30
▸ TP53 P04637 1/20 0.30
▸ CYP3A4 P08684 1/20 0.30
▸ MAPT P10636 1/20 0.30
▸ ALOX15 P16050 1/20 0.30
▸ TSHR P16473 1/20 0.30
▸ ACAT1 P24752 1/20 0.30
▸ SOAT1 P35610 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3294369 0.85 S1PR1 (0.33) CNR2CNR1TP53TSHR
SCHEMBL3298055 0.85 PPARA (0.39) CNR2CNR1TSHR
SCHEMBL3303347 0.81 KDM4E (0.34) CNR2CNR1KDM4ETP53CYP3A4
SCHEMBL3294266 0.78 CNR2 (0.34) CNR2CNR1
SCHEMBL3296697 0.77 KDM4E (0.32) CNR2KDM4ETP53CYP3A4MAPT
SCHEMBL3301783 0.76 — —
SCHEMBL3296586 0.76 CNR2 (0.33) CNR2CNR1KDM4ETP53CYP3A4
SCHEMBL3299249 0.75 KDM4E (0.32) CNR2CNR1KDM4ETP53CYP3A4
SCHEMBL3297589 0.75 CNR2 (0.46) CNR2CNR1
SCHEMBL3299957 0.74 CNR2 (0.34) CNR2CNR1KDM4ETP53CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7741393-B2 Organic silicon-based compound and method of producing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-22 — — US disclosed
US-20070203275-A1 Organic Silicon-Based Compound And Method Of Producing The Same SUMITOMO CHEMICAL COMPANY, LIMITED 2007-08-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070203275-A1 Organic Silicon-Based Compound And Method Of Producing The Same ARSA, OR10J3, HDAC10 CNR2 4285/4885CNR1 3945/4885KDM4E 1578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback